Inhibition of protein synthesis and activation of stress-activated protein kinases by onnamide A and theopederin B, antitumor marine natural products

Cancer Science

Volumn 96, Issue 6, 2005, Pages 357-364

  Lee, Kun Hyung ^a,d   Nishimura, Shinichi ^b   Matsunaga, Shigeki ^a   Fusetani, Nobuhiro ^a   Horinouchi, Sueharu ^a   Yoshida, Minoru ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d CHUBU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANISOMYCIN; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; HETEROCYCLIC COMPOUND; MITOGEN ACTIVATED PROTEIN KINASE P38; MYCALAMIDE A; NATURAL PRODUCT; ONNAMIDE A; PEDERIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; STRESS ACTIVATED PROTEIN KINASE; THEOPEDERIN B; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANIMALS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; MARINE TOXINS; MINK; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BIOSYNTHESIS; PYRANS; RATS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 22444444598     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00055.x     Document Type: Article

References (35)

1. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. [i#Cell#1i] 2000; [b#103#1b]: 295-309.
2. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. [i#Cell#1i] 2003; [b#113#1b]: 685-700.
3. Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. [i#J Biol Chem#1i] 1991; [b#266#1b]: 23048-52.
4. Burres NS, Clement JJ. Antitumor activity and mechanism of action of the ovel marine natural products mycalamide-A and -B and onnamide. [i#Cancer Res#1i] 1989; [b#49#1b]: 2935-40.
5. Ogawara H, Higashi K, Uchino K, Perry NB. Change of ras-transformed NRK-cells back to normal morphology by mycalamides A and B, antitumor agents from a marine sponge. [i#Chem Pharm Bull (Tokyo)#1i] 1991; [b#39#1b]: 2152-4.
6. Richter A, Kocienski P, Raubo P, Davies DE. The in vitro biological activities of synthetic 18-O-methyl mycalamide B, 10-epi-18-O-methyl mycalamide B and pederin. [i#Anticancer Drug Des#1i] 1997; [b#12#1b]: 217-27.
7. Hood KA, West LM, Northcote PT, Berridge MV, Miller JH. Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine. [i#Apoptosis#1i] 2001; [b#6#1b]: 207-19.
8. Gannon JV, Lane DP. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. [i#Nature#1i] 1991; [b#349#1b]: 802-6.
9. Val135). [i#J Biol Chem#1i] 2001; [b#276#1b]: 14649-57.
10. Hannigan M, Zhan L, Ai Y, Huang CK. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. [i#Biochem Biophys Res Commun#1i] 1998; [b#246#1b]: 55-8.
11. Hanafusa H, Ninomiya-Tsuji J, Masuyama N [i#et al.#1i] Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. [i#J Biol Chem#1i] 1999; [b#274#1b]: 27161-27167.
12. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S. ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. [i#J Biol Chem#1i] 1999; [b#274#1b]: 8949-57.
13. Liao JH, Chen JS, Chai MQ, Zhao S, Song JG. The involvement of p38 MAPK in transforming growth factor beta1-induced apoptosis in murine hepatocytes. [i#Cell Res#1i] 2001; [b#11#1b]: 89-94.
14. Wang L, Ma R, Flavell RA, Choi ME. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in mutrine mesangial cells. [i#J Biol Chem#1i] 2002; [b#277#1b]: 47257-62.
15. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. [i#J Biol Chem#1i] 1999; [b#274#1b]: 37413-20.
16. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. [i#EMBO J#1i] 1999; [b#18#1b]: 1345-56.
17. Hazzalin CA, Cano E, Cuenda A, Barratt MJ, Cohen P, Mahadevan LC. p38/RK is essential for stress-induced nuclear responses. JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient. [i#Curr Biol#1i] 1996; [b#6#1b]: 1028-31.
18. Bogoyevitch MA, Ketterman AJ, Sugden PH. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. [i#J Biol Chem#1i] 1995; [b#270#1b]: 29710-7.
19. Kochi SK, Collier RJ. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. [i#Exp Cell Res#1i] 1993; [b#208#1b]: 296-302.
20. Polverino AJ, Patterson SD. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor. [i#J Biol Chem#1i] 1997; [b#272#1b]: 7013-21.
21. Piel J. A polyketide synthase-peptide synthetase gene cluster from an uncultured bacterial symbiont of Paederus beetles. [i#Proc Natl Acad Sci USA#1i] 2002; [b#99#1b]: 14002-7. Epub 2002 Oct 14.
22. Piel J, Hofer I, Hui D. Evidence for a symbiosis island involved in horizontal acquisition of pederin biosynthetic capabilities by the bacterial symbiont of Paederus fuscipes beetles. [i#J Bacteriol#1i] 2004; [b#186#1b]: 1280-6.
23. Trost BM, Yang H, Probst GD. A formal synthesis of (-)-mycalamide A. [i#J Am Chem Soc#1i] 2004; [b#126#1b]: 48-9.
24. Roush WR, Pfeifer LA. Total synthesis of mycalamide A and 7-epimycalamide A. [i#Org Lett#1i] 2000; [b#2#1b]: 859-62.
25. Toyota M, Hirota M, Hirano H, Ihara M. A stereoselective synthesis of the C-10 to C-18 (right-half) fragment of mycalamides employing lewis acid promoted intermolecular aldol reaction. [i#Org Lett#1i] 2000; [b#2#1b]: 2031-4.
26. Laping NJ, Grygielko E, Mathur A [i#et al.#1i] Inhibition of transforming growth factor (TGF) -beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. [i#Mol Pharmacol#1i] 2002; [b#62#1b]: 58-64.
27. Chang L, Karin M. Mammalian MAP kinase signalling cascades. [i#Nature#1i] 2001; [b#410#1b]: 37-40.
28. Laskin JD, Heck DE, Laskin DL. The ribotoxic, stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. [i#Toxicol Sci#1i] 2002; [b#69#1b]: 289-91.
29. Cano E, Hazzalin CA, Mahadevan LC. Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and e-jun. [i#Mol Cell Biol#1i] 1994; [b#14#1b]: 7352-62.
30. Zinck R, Cahill MA, Kracht M, Sachsenmaier C, Hipskind RA, Nordheim A. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. [i#Mol Cell Biol#1i] 1995; [b#15#1b]: 4930-8.
31. Iordanov MS, Pribnow, D, Magun JL [i#et al.#1i] Ribotoxic stress response. activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA. [i#Mol Cell Biol#1i] 1997; [b#17#1b]: 3373-81.
32. Iordanov MS, Pribnow D, Magun JL, Dinh TH, Pearson JA, Magun BE. Ultraviolet radiation triggers the ribotoxic, stress response in mammalian cells. [i#J Biol Chem#1i] 1998; [b#273#1b]: 15794-803.
33. Hansen JL, Moore PB, Steitz TA. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. [i#J Mol Biol#1i] 2003; [b#330#1b]: 1061-75.
34. Nishimura S, Matsunaga S, Lee K-H [i#et al.#1i] 13-Deoxytedanolide, a marine sponge-derived antitumor macrolide, binds to 60S large ribosomal subunit. [i#Bioorg Med Chem#1i] 2004; [b#13#1b]: 449-54.
35. Carrasco L, Vazquez D. Survey of inhibitors in different steps of protein synthesis by mammalian ribosomes. [i#J Antibiot#1i] 1972; [b#25#1b]: 732-7.